Scott Dreyer - Dec 15, 2021 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role: EVP & Chief Commercial Officer
Signature: /s/ Colleen Tupper as Attorney-In-Fact For Scott Dreyer
Stock symbol: COLL
Transactions as of: Dec 15, 2021
Transactions value $: -$104,353
Form type: 4
Date filed: 12/17/2021, 03:33 PM
Previous filing: Jul 14, 2021
Next filing: Jan 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COLL	Common Stock	Sale	-$104K	-5.69K	-6.89%	$18.33	77K	Dec 15, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021 and amended on September 1, 2021.
F2	The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.95 to $18.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021 and amended on September 1, 2021.

The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.95 to $18.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).